本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Rapport Therapeutics, Inc.

11.33
-0.1400-1.22%
盤後11.330.00000.00%16:05 EDT
成交量:7.98萬
成交額:92.75萬
市值:4.14億
市盈率:-3.00
高:12.31
開:11.76
低:11.27
收:11.47
資料載入中...
2025/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/11

重要事件披露

Form 8-K - Current report
2025/03/03

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/18

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/20

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/06/14

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/06/10

重要事件披露

Form 8-K - Current report
2024/06/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/05

SEC問詢函

Form CORRESP - Correspondence
2024/06/05

SEC問詢函

Form CORRESP - Correspondence